Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C Front Oncol
B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature LEUKEMIA LYMPHOMA
Impact of Prolonged Ischemia on the Immunohistochemical Expression of Programmed Death Ligand 1 (PD-L1) APPL IMMUNOHISTO M M
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors Front Immunol
Site-directed cysteine coupling of disulfide-containing non-antibody carrier proteins (THIOCAPs) SCI CHINA MATER
Long non-coding RNAs emerge as a novel prognostic indicator in pediatric acute myeloid leukemia Transl Pediatr
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial Lancet Haematol
High-precision targeting and destruction of cancer-associated PDGFR-β(+) stromal fibroblasts through self-assembling, protein-only nanoparticles Acta Biomater